Related Experiment Video
Updated: Apr 19, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
[Adherence to oral antineoplastic therapy]
R Olivera-Fernandez1, F Fernandez-Ribeiro1, G Piñeiro-Corrales2
1Servicio de Farmacia. Complejo Hospitalario Universitario de Pontevedra.. rosario.olivera.fernandez@sergas.es.
Most patients adhere to oral chemotherapy, but 28% experience non-adherence, influenced by time from diagnosis and side effects. Improving pharmaceutical care can enhance patient adherence and manage adverse events.
Area of Science:
- Oncology
- Pharmacology
- Patient Adherence Research
Background:
- Oral chemotherapy offers advantages over intravenous administration, including cost and patient comfort.
- Challenges with oral chemotherapy include ensuring patient adherence and monitoring adverse effects.
- Effective management of oral chemotherapy requires understanding adherence patterns.
Purpose of the Study:
- To evaluate real-world adherence rates for oral chemotherapy agents.
- To identify patient and treatment factors influencing adherence.
- To explore opportunities for enhancing pharmaceutical care and patient outcomes.
Main Methods:
- Prospective, observational study conducted over four months.
- Data collected via medical prescriptions, patient history, and interviews.
- Focus on patients receiving oral chemotherapy in an outpatient setting.
Main Results:
- 141 patients were assessed, with 72% demonstrating full adherence.
- 28% of patients reported some level of non-adherence.
- Adherence was significantly influenced by time since diagnosis and the presence of adverse effects.
Conclusions:
- A 72% adherence rate was observed for oral chemotherapy.
- Identified opportunities exist to improve pharmaceutical care.
- Interventions should focus on preventing adverse effects and enhancing patient adherence.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Oral Drug Delivery Systems: Introduction
Treatment Resistent Cancers
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Treatment Resistant Cancers
Drug Therapy
Antianxiety Medications
